CARLOS HERNANDEZ-BENSON: Open Payments
NPI 1669946562 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 12 payments from 9 companies in 2025. Trend: 2023 $70 · 2024 $926 · 2025 $537
Food & beverage: $442Education: $95
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $162 |
| Legend Biotech USA Inc. | 1 | $84 |
| SANOFI US SERVICES INC. | 1 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $69 |
| Janssen Biotech, Inc. | 1 | $33 |
| Kite Pharma, Inc. | 1 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $31 |
| Incyte Corporation | 1 | $28 |
| Gamida Cell Inc. | 1 | $25 |
Products named: REZUROCK, CARVYKTI, LIVTENCITY, Cresemba, Xospata, DARZALEX, Yescarta, JAKAFI.
Industry payments across TX — which companies pay providers there.
